http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009025091-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b54923c93bd7a5be1f6b823d0d5202b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6125af14f0fbb13948b95032daeb2779
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
filingDate 2008-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f9537ed09fd31e32a9fbabb7726b72
publicationDate 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009025091-A1
titleOfInvention Pharmaceutical composition for treatment of fibromyalgia
abstract Disclosed is a novel therapeutic agent for fibromyalgia. A pharmaceutical composition comprising tizanidine as an active ingredient can be used as a therapeutic agent for fibromyalgia. The pharmaceutical composition can ameliorate a pain associated with fibromyalgia and can also ameliorate a sleep disorder, a feeling of fatigue and a depressive condition associated with fibromyalgia, and is therefore useful as a therapeutic agent for fibromyalgia.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016111357-A1
priorityDate 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003130353-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004039383-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442253

Total number of triples: 33.